NetworkNewsBreaks – Neovasc, Inc. (NVCN), Boston Scientific Corp. (BSX) Close $75M Acquisition Deal; Shares of Both Higher
Neovasc (NASDAQ: NVCN) and Boston Scientific (NYSE: BSX) this morning reported the close of their previously announced $75 million agreement in which Boston Scientific has acquired Neovasc's advanced biologic tissue capabilities and certain manufacturing assets, as well as 11,817,000 common shares at a price of $0.60 each ($7.0 million) for a 15% equity interest in Neovasc. Per the agreement, Neovasc has been granted a license to the purchased assets and access to the facilities in order to continue its assembly activities for its remaining tissue and valve customers. Neovasc said it intends to use the proceeds of these transactions toward…